• 1. Exclusive enantioselective recognition of glucopyranosides by inherently chiral hemicryptophanes?
  Olivier Perraud,Alexandre Martinez,Jean-Pierre Dutasta Chem. Commun., 2011,47, 5861-5863
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

Introduction to 3-(3-Methoxyphenyl)cyclohexanone (CAS No. 171046-93-8)

3-(3-Methoxyphenyl)cyclohexanone, identified by the Chemical Abstracts Service Number (CAS No.) 171046-93-8, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, featuring a cyclohexanone core substituted with a 3-methoxyphenyl group, has garnered attention due to its versatile structural framework and potential applications in medicinal chemistry. The presence of both aromatic and cyclic functionalities makes it a valuable scaffold for further derivatization and exploration in drug discovery programs.

The 3-methoxyphenyl moiety introduces a hydroxyl group that is methoxylated, which can influence the electronic properties and reactivity of the molecule. This substitution pattern is commonly found in biologically active compounds, where methoxy groups often enhance binding affinity to biological targets. The cyclohexanone ring, on the other hand, provides a rigid yet flexible structure that can be modified through various chemical reactions, such as oxidation, reduction, or functional group interconversion.

In recent years, there has been growing interest in exploring the pharmacological properties of 3-(3-Methoxyphenyl)cyclohexanone and its derivatives. Researchers have been investigating its potential as an intermediate in the synthesis of novel therapeutic agents. The compound’s ability to serve as a precursor for more complex molecules has made it a focal point in synthetic organic chemistry. Additionally, its structural features have led to studies on its possible role as an enzyme inhibitor or modulator of signaling pathways.

One of the most compelling aspects of 3-(3-Methoxyphenyl)cyclohexanone is its utility in the development of small-molecule probes for biochemical studies. The combination of aromatic and cyclic structures allows for interactions with a wide range of biological targets, making it a promising candidate for high-throughput screening assays. Recent advances in computational chemistry have enabled researchers to predict the binding modes of this compound with various proteins, facilitating the design of more effective derivatives.

The synthesis of 3-(3-Methoxyphenyl)cyclohexanone has been optimized through multiple pathways, each offering distinct advantages in terms of yield and purity. One common approach involves the Friedel-Crafts acylation followed by reduction, while another method employs cross-coupling reactions to introduce the phenyl ring. These synthetic strategies have been refined over time to ensure scalability and reproducibility, which are critical for industrial applications.

From a medicinal chemistry perspective, 3-(3-Methoxyphenyl)cyclohexanone has shown promise in preclinical studies as a lead compound for treating various diseases. Its structural motif is reminiscent of several known pharmacophores that exhibit anti-inflammatory, antiviral, and anticancer activities. By leveraging computational modeling and structure-activity relationship (SAR) studies, researchers aim to enhance the biological efficacy of this compound while minimizing potential side effects.

The role of 3-(3-Methoxyphenyl)cyclohexanone in drug discovery is further underscored by its compatibility with modern synthetic techniques such as flow chemistry and biocatalysis. These methods allow for efficient production of complex molecules under controlled conditions, reducing waste and improving sustainability. As the pharmaceutical industry moves toward greener chemistry practices, compounds like 3-(3-Methoxyphenyl)cyclohexanone that can be synthesized using these advanced techniques are becoming increasingly valuable.

In conclusion, 3-(3-Methoxyphenyl)cyclohexanone (CAS No. 171046-93-8) represents a fascinating subject of study in organic and medicinal chemistry. Its unique structural features and potential applications make it a cornerstone in ongoing research efforts aimed at developing novel therapeutic agents. As scientific understanding continues to evolve, it is likely that this compound will play an even greater role in shaping the future of drug discovery and development.

• 52498-02-9(3-(4-methoxyphenyl)cyclobutan-1-one)
• 5309-16-0(4-(4-methoxyphenyl)cyclohexan-1-one)
• 15547-89-4(2-(3-Methoxyphenyl)cyclohexanone)
• 116526-34-2(Cyclopentanone,3-(4-methoxyphenyl)-)
• 190064-28-9(5-(3,4-Dimethoxyphenyl)cyclohexane-1,3-dione)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)